Coloma Jason V sold MAZE
November 2, 2026 · Form 4 insider transaction
Coloma Jason V sold 5,345 shares of Maze Therapeutics, Inc. at $31.05 per share, a transaction worth $166.0K. The trade was recorded as open-market sale under a pre-scheduled Rule 10b5-1 plan and disclosed on an SEC Form 4, filed 2 days after the transaction.
Footnotes
This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on February 6, 2026.; The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $30.795 to $31.70 per share, inclusive.; Reflects the transfer of 27,362 shares of Common Stock by the reporting person to the Coloma Family Trust on November 3, 2026.; These securities are directly held by the Coloma Family Trust, for which the reporting person and his spouse serve as co-trustees.